Findings of 18 F-Fluorodeoxyglucose Positron-Emission Tomography in Methotrexate-Related Lymphoproliferative Disorder
暂无分享,去创建一个
[1] K. Kubota,et al. Clinical Role of FDG PET/CT for Methotrexate-Related Malignant Lymphoma , 2011, Clinical nuclear medicine.
[2] M. Kojima,et al. Methotrexate-Related Epstein-Barr Virus (EBV)-Associated Lymphoproliferative Disorder—So-Called “Hodgkin-Like Lesion”—of the Oral Cavity in a Patient with Rheumatoid Arthritis , 2010, Head and neck pathology.
[3] R. Jankowitz,et al. A Putative Case of Methotrexate-Related Lymphoma: Clinical Course and PET/CT Findings , 2009, Case reports in medicine.
[4] D. M. van der Heijde,et al. Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research , 2008, Annals of the rheumatic diseases.
[5] Jeffrey R Curtis,et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. , 2008, Arthritis and rheumatism.
[6] M. Roarke,et al. Methotrexate-induced and Epstein-Barr virus-associated B-cell lymphoma of the spine: MR and PET/CT imaging. , 2008, Clinical nuclear medicine.
[7] N. Shinton. WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues , 2007 .
[8] T. Nihashi,et al. 18F-FDG PET for Posttherapy Assessment of Hodgkin's Disease and Aggressive Non-Hodgkin's Lymphoma: A Systematic Review , 2007, Journal of Nuclear Medicine.
[9] K. Kishi,et al. Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: Relationship with type of latent Epstein‐Barr virus infection , 2007, American journal of hematology.
[10] Klemens Scheidhauer,et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Y. Tomita,et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. , 2007, The Journal of rheumatology.
[12] J. Armitage,et al. F-18-fluoro-deoxy-glucose positron emission tomography in the assessment of peripheral T-cell lymphomas , 2007, Leukemia & lymphoma.
[13] G. Mackie,et al. Methotrexate-induced pulmonary non-Hodgkin lymphoma. , 2006, Clinical nuclear medicine.
[14] B Combe,et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) , 2006, Annals of the rheumatic diseases.
[15] Y. Erdi,et al. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] S. Fischer,et al. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas. , 2004, Journal of the National Cancer Institute.
[17] J. Leonard,et al. Comparison of fluorine‐18 fluorodeoxyglucose positron emission tomography and Ga‐67 scintigraphy in evaluation of lymphoma , 2002, Cancer.
[18] H. Griesser,et al. Lymphomas in patients with connective tissue disease. Comparison of p53 protein expression and latent EBV infection in patients immunosuppressed and not immunosuppressed with methotrexate. , 2000, American journal of clinical pathology.
[19] R. Warnke,et al. Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. , 1994, Human pathology.
[20] R. Warnke,et al. Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. , 1993, The New England journal of medicine.
[21] H. Hurwitz,et al. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. , 1991, The Journal of rheumatology.
[22] M Tubiana,et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] A. Serafini,et al. FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease. , 2010, Radiographics : a review publication of the Radiological Society of North America, Inc.
[24] S. Schwartzman,et al. Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment. , 1997, Seminars in arthritis and rheumatism.